{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:41:32Z","timestamp":1794357692042,"version":"4.9.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZCLQ24H1602"],"award-info":[{"award-number":["ZCLQ24H1602"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403401"],"award-info":[{"award-number":["82403401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.redox.2025.103721","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T01:26:59Z","timestamp":1749346019000},"page":"103721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through the FAK\/AKT\/Mtor-gpx4 cascade"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6021-7723","authenticated-orcid":false,"given":"Peng","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10242","key":"10.1016\/j.redox.2025.103721_bib2","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Pt 2","key":"10.1016\/j.redox.2025.103721_bib4","article-title":"Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: environmental factors, molecular profile and drug\/nanotherapeutic approaches","volume":"240","author":"Ashrafizadeh","year":"2024","journal-title":"Environ. Res."},{"issue":"6","key":"10.1016\/j.redox.2025.103721_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"26","key":"10.1016\/j.redox.2025.103721_bib7","article-title":"Ferroptosis, necroptosis, and pyroptosis in gastrointestinal cancers: the chief culprits of tumor progression and drug resistance","volume":"10","author":"Zhu","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.redox.2025.103721_bib10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/14737140.2024.2438951","article-title":"NRF2\/KEAP1 signaling inhibitors in gynecologic cancers","volume":"24","author":"Fantone","year":"2024","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"24","key":"10.1016\/j.redox.2025.103721_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413239","article-title":"Nrf2 signaling in renal cell carcinoma: a potential candidate for the development of novel therapeutic strategies","volume":"25","author":"Schiavoni","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.redox.2025.103721_bib12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.redox.2025.103721_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.redox.2025.103721_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"issue":"7","key":"10.1016\/j.redox.2025.103721_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","article-title":"Ferroptosis as a potential target for cancer therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.redox.2025.103721_bib17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","article-title":"Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2025.103721_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216119","article-title":"Targeting GPX4 in human cancer: implications of ferroptosis induction for tackling cancer resilience","volume":"559","author":"Lee","year":"2023","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.redox.2025.103721_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104777","article-title":"The role of tetraspanins pan-cancer","volume":"25","author":"Huang","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrc3640","article-title":"Tetraspanin proteins promote multiple cancer stages","volume":"14","author":"Hemler","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.redox.2025.103721_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tcb.2023.09.003","article-title":"Tetraspanins: structure, dynamics, and principles of partner-protein recognition","volume":"34","author":"Susa","year":"2024","journal-title":"Trends Cell Biol."},{"issue":"36","key":"10.1016\/j.redox.2025.103721_bib22","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1074\/jbc.RA120.012601","article-title":"The tetraspanin Tspan15 is an essential subunit of an ADAM10 scissor complex","volume":"295","author":"Koo","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.redox.2025.103721_bib23","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/liv.15691","article-title":"Tspan15-ADAM10 signalling enhances cancer stem cell-like properties and induces chemoresistance via Notch1 activation in ICC","volume":"43","author":"Yoshizumi","year":"2023","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41467-018-03716-9","article-title":"TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-kappaB signaling","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.redox.2025.103721_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111622","article-title":"Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma","volume":"384","author":"Hiroshima","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"21\u201322","key":"10.1016\/j.redox.2025.103721_bib26","article-title":"Tspan15 is a new stemness-related marker in hepatocellular carcinoma","volume":"19","author":"Sidahmed-Adrar","year":"2019","journal-title":"Proteomics (Weinh.)"},{"key":"10.1016\/j.redox.2025.103721_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","article-title":"Tumor-stroma TGF-beta1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin alpha(v)beta(3)\/CD36-mediated activation of the MAPK pathway","volume":"528","author":"Nan","year":"2022","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.redox.2025.103721_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","article-title":"Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma","volume":"29","author":"Peng","year":"2019","journal-title":"Cell Res."},{"issue":"17","key":"10.1016\/j.redox.2025.103721_bib29","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00018-018-2791-2","article-title":"In vivo regulation of the A disintegrin and metalloproteinase 10 (ADAM10) by the tetraspanin 15","volume":"75","author":"Seipold","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.redox.2025.103721_bib30","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1074\/jbc.M115.703058","article-title":"TspanC8 tetraspanins and A disintegrin and metalloprotease 10 (ADAM10) interact via their extracellular regions: EVIDENCE for distinct binding mechanisms for different TspanC8 proteins","volume":"291","author":"Noy","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.redox.2025.103721_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells13080708","article-title":"GW501516-Mediated targeting of tetraspanin 15 regulates ADAM10-dependent N-cadherin cleavage in invasive bladder cancer cells","volume":"13","author":"Barbaud","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.redox.2025.103721_bib32","doi-asserted-by":"crossref","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","article-title":"Barriers and opportunities for gemcitabine in pancreatic cancer therapy","volume":"324","author":"Beutel","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.redox.2025.103721_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741","author":"de Sousa Cavalcante","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2025.103721_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103349","article-title":"UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling","volume":"76","author":"Song","year":"2024","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-021-01466-9","article-title":"CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma","volume":"21","author":"Chen","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","article-title":"GPX4-independent ferroptosis-a new strategy in disease's therapy","volume":"8","author":"Ma","year":"2022","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.redox.2025.103721_bib37","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","article-title":"Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.redox.2025.103721_bib39","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41418-022-00939-8","article-title":"EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma","volume":"29","author":"Yuan","year":"2022","journal-title":"Cell Death Differ."},{"issue":"14","key":"10.1016\/j.redox.2025.103721_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143377","article-title":"Integrin beta1 in pancreatic cancer: expressions, functions, and clinical implications","volume":"14","author":"Li","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-023-01338-3","article-title":"Integrinbeta-1 in disorders and cancers: molecular mechanisms and therapeutic targets","volume":"22","author":"Su","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"12","key":"10.1016\/j.redox.2025.103721_bib42","article-title":"B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin alpha2beta1-mediated FAK and AKT activation","volume":"5","author":"Tang","year":"2023","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.redox.2025.103721_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7150\/ijbs.86317","article-title":"Hypoxia-driven TNS4 fosters HNSCC tumorigenesis by stabilizing integrin alpha5beta1 complex and triggering FAK-mediated Akt and TGFbeta signaling pathways","volume":"20","author":"Zhao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.redox.2025.103721_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.celrep.2015.09.024","article-title":"Interplay of endosomal pH and ligand occupancy in integrin alpha5beta1 ubiquitination, endocytic sorting, and cell migration","volume":"13","author":"Kharitidi","year":"2015","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.redox.2025.103721_bib45","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1172\/JCI122779","article-title":"Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin beta1","volume":"129","author":"Zhao","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.redox.2025.103721_bib46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2025.103721_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115820","article-title":"Venetoclax in adult acute myeloid leukemia","volume":"168","author":"Hu","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725002344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725002344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:48:57Z","timestamp":1779446937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"alternative-id":["S2213231725002344"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103721","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through the FAK\/AKT\/Mtor-gpx4 cascade","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103721"}}